You are here

Clinical Trials: Eye Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Sunday, October 2, 2016 - 12:00
Conditions:   Hereditary Corneal Dystrophy;   Keratoconus
Interventions:   Procedure: Lipoaspiration;   Procedure: Transplantation
Sponsors:   Vissum, Instituto Oftalmológico de Alicante;   Reviva Pharmaceuticals;   Hospital Universitario La Paz;   LASER VISION CENTER IN LIBANON;   OPTICA GENERAL IN LIBANON
Recruiting - verified October 2016
Posted: Monday, August 1, 2016 - 12:00
Condition:   Glaucoma
Interventions:   Drug: NT-501 ECT implant;   Other: Sham
Sponsor:   Stanford University
Recruiting - verified August 2016
Posted: Saturday, March 26, 2016 - 12:00
Condition:   Dry Age-related Macular Degeneration
Intervention:   Biological: retinal pigment epithelium transplantation
Sponsors:   Chinese Academy of Sciences;   Beijing Tongren Hospital
Recruiting - verified December 2016
Posted: Monday, March 7, 2016 - 12:00
Conditions:   Age Related Macular Degeneration;   Stargardt's Disease;   Exudative Age-related Macular Degeneration
Interventions:   Procedure: injection of hESC-RPE in suspension;   Procedure: injection hESC-RPE seeded in a substrate
Sponsor:   Federal University of São Paulo
Recruiting - verified September 2016
Posted: Friday, February 26, 2016 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Biological: Stem Cell Transplantation
Sponsor:   Stem Cells Arabia
Recruiting - verified February 2016
Posted: Thursday, January 7, 2016 - 12:00
Conditions:   Macular Degeneration;   Stargardt's Macular Dystrophy
Intervention:   Procedure: Subretinal transplantation
Sponsor:   Southwest Hospital, China
Recruiting - verified April 2016
Posted: Wednesday, December 23, 2015 - 12:00
Condition:   Optic Neuropathy
Intervention:   Biological: Stem Cells
Sponsor:   Stem Cells Arabia
Recruiting
Posted: Friday, October 23, 2015 - 12:00
Conditions:   Dry Macular Degeneration;   Geographic Atrophy
Intervention:   Biological: CPCB-RPE1
Sponsor:   Regenerative Patch Technologies, LLC
Recruiting - verified January 2016
Posted: Wednesday, June 10, 2015 - 12:00
Condition:   Uveitis
Intervention:   Other: intravitreous administration of regulator T-cells
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2015
Posted: Monday, May 18, 2015 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Drug: hRPC
Sponsor:   ReNeuron Limited
Recruiting - verified December 2015

Pages